Weight of accepted product used for take-back, reuse or disposal
Unit
i
The unit(s) of measurement applicable to the metric.
: Metric tonnes (t)
Indicator
i
Indicators were developed by WBCSD. Learn more on the Methodology page.
: Waste minimized, reused, composted or recycled
Metric type
i
The category of nature-related metrics. Learn more on the Methodology page.
: Response
Framework alignment notes
i
The details of a metric’s alignment to each framework, including where the same or similar metric can be found within the listed framework.
ESRS E5-5 37c, E5-5 AR 28
GRI 306-2
SASB HC-BP-250a.4
Refer to the PSCI's Decarbonization Playbook for the Pharmaceutical Industry for alignment to the metric
GBF Target 16
Target example
i
An example target and the target source are presented to illustrate how a target could be set for this metric. Learn more on the Methodology page.
[Company name] will increase the total weight of product accepted through take-back programs by [target amount, in absolute tonnes or percentage] by [target year], compared to a [baseline year] baseline
Each metric applies to one or more stages of the value chain aligned with the associated actions.
ManufacturingEnd of Life
Metric assessment
i
The relevance and feasibility scores were determined by WBCSD member companies. Learn more on the Methodology page.
Relevance:High
Feasibility:Low
Related actions
i
The other actions that the metric is mapped to.
Reduce solid waste generated from the disposal of used pharmaceutical products through public education and information campaigns encouraging correct packaging and device disposal
Reduce APIs (including antibiotics) in the environment through public education and information campaigns encouraging correct medicine disposal
Minimize waste from single-use packaging by redesigning products and systems to prioritize circularity
Design processes and products to minimize waste and maximize circularity